跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENZYPLEX TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
ENZYPLEX TABLET
Approved
THERAPEUTIC
ENZYPLEX TABLET
PT MEDIFARMA LABORATORIES INC
🇸🇬 Health Sciences Authority
Approval Date
May 3, 1991
Approval ID
abb31ad81f660dbc
Company
PT MEDIFARMA LABORATORIES INC
Type
Therapeutic
Approval Details
Approval Id
abb31ad81f660dbc
Drug Name
ENZYPLEX TABLET
Product Name
ENZYPLEX TABLET
Approval Number
SIN06211P
Approval Date
1991-05-03
Registrant
ZUELLIG PHARMA PTE. LTD.
Licence Holder
ZUELLIG PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
ENTERIC COATED TABLET
Route Of Administration
ORAL
Atc Code
A09AA02
Atc Item Name
multienzymes (lipase, protease etc.)
Pharma Manufacturer Name
ZUELLIG PHARMA PTE. LTD.
Company Detail Path
/organization/zuellig-pharma-pte-ltd
Active Ingredients
THIAMINE
10 mg
RIBOFLAVIN
5 mg
PYRIDOXINE
5 mg
NIACINAMIDE
10 mg
LIPASE
240 u
AMYLASE
10000 u
CYANOCOBALAMIN
5 mcg
PROTEASE
9000 u
DESOXYCHOLIC ACID
30 mg
DIMETHYLPOLYSILOXANE
25 mg
CALCIUM PANTOTHENATE
5 mg
AMYLASE
10,000 UNITS
CALCIUM PANTOTHENATE
5 MG
CYANOCOBALAMIN
5 MCG
DESOXYCHOLIC ACID
30 MG
DIMETHYLPOLYSILOXANE
25 MG
LIPASE
240 UNITS
NIACINAMIDE
10 MG
PROTEASE
9,000 UNITS
PYRIDOXINE
5 MG
RIBOFLAVIN
5 MG
THIAMINE
10 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 3, 1991
Approval ID
abb31ad81f660dbc
Type
Therapeutic
Back to HSA Approvals